Cited by 222

The DOI matches its Crossref record.

Effects of Ursodeoxycholic Acid and Aspirin on the Formation of Lithogenic Bile and Gallstones during Loss of Weight

Broomfield, Paul H., Chopra, Rakesh, Sheinbaum, Richard C., Bonorris, George G., Silverman, Alan, Schoenfield, Leslie J., Marks, Jay W.·1988·New England Journal of Medicine

Abstract

We attempted to determine whether the administration of aspirin or ursodeoxycholic acid during loss of weight could prevent the development of lithogenic changes in bile and the formation of gallstones. Sixty-eight obese subjects without gallstones who were entered in a program (520 kcal per day) to lose weight were randomly assigned to receive ursodeoxycholic acid (1200 mg per day), aspirin (1300 mg per day), or placebo in double-blind fashion for up to 16 weeks. At entry, at four weeks of treatment, and at three weeks after the completion of treatment, the subjects underwent ultrasonography to detect gallstones and duodenal drainage of bile to detect cholesterol crystals and to determine the bile saturation index and glycoprotein concentration. No gallstones or cholesterol crystals formed in the patients treated with ursodeoxycholic acid. Among the patients given placebo, gallstones formed in five (P less than 0.05 vs. ursodeoxycholic acid) and cholesterol crystals in six (P less than 0.001 vs. ursodeoxycholic acid); among those given aspirin, gallstones formed in two and cholesterol crystals in one (no significant difference from ursodeoxycholic acid treatment). By the fourth week, the bile saturation index increased in the placebo group (from 1.07 +/- 0.26 to 1.29 +/- 0.27; P less than 0.001), decreased in the ursodeoxycholic acid group (from 1.11 +/- 0.34 to 0.91 +/- 0.24; P less than 0.001), and did not change significantly in the aspirin group. The concentration of gly…

Overview

Integrity signals

Registry

Crossref · 10.1056/nejm198812153192403

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Previous studies of VLCD-induced rapid weight loss have generally been small, of short duration, lacked control groups and used formulations with lower amounts of fat compared with formulations used today.

    “Previous studies of VLCD-induced rapid weight loss have generally been small, of short duration, lacked control groups and used formulations with lower amounts of fat compared with the formulations used today.10, 11, 12, 13, 14”
  • Extremely rapid (>1.5 kg/week) or excessive weight reduction (>25% of total body weight) may lead to a lithogenic state and initiate biliary sludge and gallstones.

    “However, the following two specific settings are exceptions: extremely rapid (>1.5 kg/week) or excessive weight reduction (>25% of the total body weight) [202122]. Both cases may occur after bariatric surgery or administration of weight loss medications, which may lead to a lithogenic state and subsequently initiate biliary sludge and gallstones [22].”
  • The prophylactic use of UDCA during the weight reduction phase, regardless of the method of weight loss, has been proven to reduce gallstone formation, with reduction rates up to 58% in a few clinical trials.

    “The prophylactic use of UDCA during the weight reduction phase, regardless of the method of weight loss (low-calorie diet, bariatric surgery, etc.), has been proven to reduce gallstone formation, with reduction rates of up to 58% in a few clinical trials [2025444546474849].”

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 38

  1. Newman, 1959, Int Abstr Surg, 109, 1
  2. Freeman, 1975, Am J Surg, 129, 163, 10.1016/0002-9610(75)90292-5 · DOI · Paper page
  3. Mabee, 1976, Surgery, 79, 460
  4. Mok, 1979, Gastroenterology, 76, 556, 10.1016/S0016-5085(79)80225-5 · DOI
  5. Friedman, 1966, J Chronic Dis, 19, 273, 10.1016/0021-9681(66)90132-9 · DOI
  6. Burnett, 1971, Tijdschr Gastroenterol, 14, 79
  7. Amaral, 1985, Am J Surg, 149, 551, 10.1016/S0002-9610(85)80055-6 · DOI · Paper page
  8. Holzbach, 1973, J Clin Invest, 52, 1467, 10.1172/JCI107321 · DOI
  9. Carey, 1978, J Clin Invest, 61, 998, 10.1172/JCI109025 · DOI
  10. Holan, 1979, Gastroenterology, 77, 611, 10.1016/0016-5085(79)90209-9 · DOI
  11. Levy, 1984, Gastroenterology, 87, 270, 10.1016/0016-5085(84)90700-5 · DOI
  12. Gallinger, 1985, Gastroenterology, 89, 648, 10.1016/0016-5085(85)90464-0 · DOI
  13. Womack, 1971, Surg Gynecol Obstet, 133, 937
  14. Freston, 1969, Gastroenterology, 57, 670, 10.1016/S0016-5085(19)33822-3 · DOI
  15. Lee, 1981, J Clin Invest, 67, 1712, 10.1172/JCI110209 · DOI
  16. Lee, 1981, Science, 211, 1429, 10.1126/science.7466399 · DOI
  17. Bennion, 1975, J Clin Invest, 56, 996, 10.1172/JCI108180 · DOI
  18. Nestel, 1973, J Clin Invest, 52, 2389, 10.1172/JCI107428 · DOI
  19. Nilsell, 1983, Gastroenterology, 85, 1248, 10.1016/S0016-5085(83)80003-1 · DOI
  20. Thistle, 1971, Gastroenterology, 61, 488, 10.1016/S0016-5085(19)33499-7 · DOI
  21. Talalay, 1960, Methods Biochem Anal, 8, 119, 10.1002/9780470110249.ch3 · DOI
  22. Schoenfield, 1973, J Lab Clin Med, 82, 858
  23. Fiske, 1925, J Biol Chem, 66, 375, 10.1016/S0021-9258(18)84756-1 · DOI
  24. Thomas, 1973, Gastroenterology, 65, 698, 10.1016/S0016-5085(19)33056-2 · DOI
  25. Hegardt, 1971, Z Ernahrungswiss, 10, 223, 10.1007/BF02020933 · DOI
  26. Carey MC, Ko G. The importance of total lipid concentration in determining cholesterol solubility in bile and the development of critical tables for calculating 'percent cholesterol saturation' with a correction factor for ursodeoxycholate-rich bile. In: Paumgartner G, Stiehl A, Gerok W, eds. Biological effects of bile acids. Baltimore, Md.: University Park Press, 1979:299–308.
  27. Pearson, 1982, Biochim Biophys Acta, 706, 221, 10.1016/0167-4838(82)90490-3 · DOI
  28. Winer BJ. Statistical principles in experimental design. 2nd ed. New York: McGraw-Hill, 1971:149–60.
  29. Dixon WJ, Massey FJ Jr. Introduction to statistical analysis. 3rd ed. New York: McGraw-Hill, 1969:109–23, 243.
  30. Fleiss JL. The design and analysis of clinical experiments. New York: John Wiley, 1986:118.
  31. Knecht, 1978, Am Surg, 44, 496
  32. Wattchow, 1983, Br Med J, 286, 763, 10.1136/bmj.286.6367.763 · DOI
  33. Van der Linden, 1974, Gut, 15, 630, 10.1136/gut.15.8.630 · DOI
  34. Whiting, 1982, Surg Gastroenterol, 1, 17
  35. Mok, 1979, Gastroenterology, 76, 556, 10.1016/S0016-5085(79)80225-5 · DOI
  36. LaMont, 1984, Hepatology, 4, 51S, 10.1002/hep.1840040809 · DOI
  37. LaMont, 1982, Gastroenterology, 82, 1110
  38. LaMorte, 1985, Surgery, 98, 445

Cited by

Sorted by citations

Metadata

Authors
Broomfield, P. H., Chopra, R., Sheinbaum, R. C., Bonorris, G. G., Silverman, A., Schoenfield, L. J., & Marks, J. W.
Venue
New England Journal of Medicine
Published
1988-12-15
Volume
319
Issue
24
Pages
1567-1572
ISSN
  • 0028-4793
  • 1533-4406
Cited by
222
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review